Melina Elpi Marmarelis, MD
Medical Oncology, Hematology
Headshot of Melina Elpi Marmarelis, MD

Melina Elpi Marmarelis, MD

Medical Oncology, Hematology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
View 1 additional location
Headshot of Melina Elpi Marmarelis, MD
Penn Medicine Provider

About me

  • Medical Director, Penn Mesothelioma Program
  • Associate Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania

My education and training

  • Harvard Medical SchoolMedical School
  • Massachusetts General Hospital/Brigham and Women’s HospitalResidency
  • University of Pennsylvania Health SystemResidency

Spoken languages

English
English

Reviews

Average Rating

508 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
October 2026
Knowledgeable and professional
Anonymous
October 2026
Just , thank you
Anonymous
October 2026
She is the best!!!!!!!
Anonymous
October 2026
She is definitely an expert in her field

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Marmarelis is a Penn Medicine provider.

Qualifications and experience

All conditions and treatments

Research

Publications

Melina E. Marmarelis, Li Zhang, Ning Li, Gerald Falchook, Sheena Sahota, Yanqiu Zhao, Amit Mahipal, Melissa Johnson, Halle Zhang, Lan Liu, Wenhao Duanmu, Ranchi Xu, Yiman Li, Jianfei Wan, Chen Wang, Juegang Ju, Qinhan Chen, Feng Ren, Alex Zhavoronkov, Hedy Lee Kindler First-in-human Multicenter Phase 1 Study of ISM6331, an AI-Designed Pan-TEAD Inhibitor, in Patients with Mesothelioma or Other Advanced Solid Tumors , ESMO Annual Meeting Rapid Oral Presentation, Madrid, Spain: 2026


Andrea E Ferris, Nathalie Daaboul, Benjamin A Bleiberg, Chunxia Su, Yasushi Goto, William Nassib William Jr, Melina E Marmarelis, Leah Phillips, Dave Bjork, Shani Shilo, Simon Fifer, Maya Joshi, Brittany Keen, Francisca Maron, Jefferson Alves, Michelle Hull, Ellen Janssen, Anjali Shah, Yin Wan, Wade Iam MyChoice: Global study evaluating patient & physician treatment preferences in first-line metastatic common EGFR-mutated NSCLC (poster presentation) , ESMO Annual Meeting, Madrid, Spain: 2026


W. Wang, D. Huth, C. Davis, X. Wang, D. Cantor, A. Singh, L. Sun, C. D’Avella, D. Dougherty, K. Robinson, R. Cohen, C. Langer, M. Marmarelis, C. Aggarwal P2.091Real-World Implementation of Tumor-Informed ctDNA MRD Testing in Early-Stage NSCLC: Initial Experience From a Large Academic Center , WCLC 2026 Poster: 2026


X. Wang; A. Martella; A. Watts; E.P. Wileyto; P. Gabriel; A. Montgomery; K. Rendle; M. Marmarelis; C. Aggarwal P2.092 - Inudge: Integration of Liquid Biopsy Based Next Generation Gene Sequencing in Newly Diagnosed NSCLC - Results From a Prospective Clinical Trial , WCLC 2026 Poster: 2026


Kleeman SO, Riazat-Kesh Y, Carvajal R, Marmarelis ME, Schadendorf D, Sharon E, Othus M, Robert C, Skoulidis F, Izar B, Maki RG, Janowitz T. Cancer Chemoimmunotherapy: Time Will Tell , Cancer Immunol Res, 14: 2026,1212-1215


Barsouk AA, Yaskolko M, Sussman JH, Sun L, Singh AP, Cohen RB, Aggarwal C, Marmarelis ME, Langer CJ. Poor Performance Status Associated With Inferior Tarlatamab Outcomes in a Large, Multi-institution Real-World Database of Patients With 2L + ES-SCLC , Clin Lung Cancer, 27: 2026,50-55


Melina E. Marmarelis, Adrienne M. Gilligan, Tomoko Sugihara, Tyler Marquart, Sam Whipple, Yufei Wang, Taylor J Allen-Coyle, Naleen Raj Bhandari, Charu Aggarwal The Waiting Game: How NGS and Guideline-Concordant-Care Timing Shape Survival in Advanced NSCLC , Cancers, 18(14): 2026,2287


Sam O. Kleeman; Yosef Riazat-Kesh; Richard Carvajal; Melina E. Marmarelis; Dirk Schadendorf; Elad Sharon; Megan Othus; Caroline Robert; Ferdinandos Skoulidis; Benjamin Izar; Robert G. Maki; Tobias Janowitz. Cancer chemo-immunotherapy: time will tell , Cancer Immunology Research: 2026


Benjamin A. Bleiberg, Lauren Reed-Guy, Roger B. Cohen, Charu Aggarwal, Corey J. Langer, Aditi P. Singh, Melina E. Marmarelis Carboplatin plus Pemetrexed versus Pemetrexed alone in Advanced Thymoma and Thymic Carcinoma: A Retrospective Cohort Study , Frontiers: 2026


Benjamin A. Bleiberg, Dylan G. Scholes, Lauren Reed-Guy, Devaki Dravid, Lova L. Sun, Aditi P. Singh, Roger B. Cohen, Corey J. Langer, Melina E. Marmarelis, Charu Aggarwal The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing , The Journal of Liquid Biopsy, 12: 2026